Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (544) 544
science & technology (458) 458
life sciences & biomedicine (457) 457
zygomycosis (353) 353
antifungal agents - therapeutic use (321) 321
male (311) 311
zygomycosis - drug therapy (264) 264
infectious diseases (245) 245
female (204) 204
mucormycosis (201) 201
middle aged (179) 179
adult (170) 170
zygomycosis - diagnosis (166) 166
biological and medical sciences (165) 165
medical sciences (164) 164
mycoses (162) 162
amphotericin b - therapeutic use (158) 158
microbiology (134) 134
zygomycosis - microbiology (126) 126
immunocompromised host (107) 107
mucormycosis - drug therapy (107) 107
treatment outcome (102) 102
human mycoses (100) 100
mycology (100) 100
health aspects (94) 94
aged (88) 88
child (85) 85
triazoles - therapeutic use (85) 85
amphotericin b (83) 83
zygomycosis - pathology (83) 83
fungal infections (81) 81
risk factors (81) 81
dermatology (80) 80
immunology (76) 76
antifungal agents - administration & dosage (75) 75
tropical mycoses (75) 75
phycomycoses (74) 74
adolescent (73) 73
fungi (73) 73
transplantation (72) 72
care and treatment (68) 68
aspergillosis (64) 64
antifungal agents (62) 62
diagnosis (61) 61
zygomycosis - complications (59) 59
fatal outcome (58) 58
infections (58) 58
mucormycosis - microbiology (55) 55
mucormycosis - diagnosis (54) 54
mycoses - drug therapy (53) 53
child, preschool (52) 52
mortality (52) 52
rhizopus - isolation & purification (51) 51
animals (50) 50
zygomycosis - epidemiology (50) 50
zygomycosis - surgery (50) 50
amphotericin b - administration & dosage (49) 49
surgery (48) 48
posaconazole (47) 47
voriconazole (47) 47
zygomycosis - etiology (47) 47
itraconazole - therapeutic use (44) 44
oncology (44) 44
diagnosis, differential (43) 43
pediatrics (43) 43
pharmacology & pharmacy (43) 43
zygomycosis - therapy (43) 43
diabetes (42) 42
debridement (41) 41
rhizopus (41) 41
pharmacology. drug treatments (40) 40
young adult (40) 40
case studies (39) 39
antiparasitic agents (38) 38
drug therapy, combination (38) 38
hematology (38) 38
dermatomycoses - drug therapy (36) 36
infection (36) 36
antibiotics. antiinfectious agents. antiparasitic agents (35) 35
epidemiology (34) 34
antifungal agents - pharmacology (33) 33
pathology (33) 33
mucormycosis - pathology (32) 32
tomography, x-ray computed (32) 32
tropical medicine (32) 32
aspergillosis - drug therapy (31) 31
general & internal medicine (31) 31
research (31) 31
veterinary sciences (31) 31
leukemia (30) 30
lung diseases, fungal - drug therapy (30) 30
mucorales (30) 30
mucormycosis - etiology (30) 30
retrospective studies (30) 30
candidiasis (29) 29
drug therapy (29) 29
entomophthorales - isolation & purification (29) 29
infant (29) 29
biopsy (28) 28
combined modality therapy (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (616) 616
German (21) 21
Japanese (9) 9
French (7) 7
Spanish (7) 7
Portuguese (6) 6
Chinese (2) 2
Dutch (2) 2
Hungarian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Delaying Amphotericin B-Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis
by Georgios Chamilos and Russell E. Lewis and Dimitrios P. Kontoyiannis
Clinical infectious diseases, ISSN 1058-4838, 8/2008, Volume 47, Issue 4, pp. 503 - 509
Antifungals | Health outcomes | Delayed diagnosis | Mortality | Hematologic neoplasms | Articles and Commentaries | Aspergillosis | Infections | Fungal infections | Symptoms | Zygomycosis | Human mycoses | Infectious diseases | Tropical mycoses | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Antiparasitic agents | Phycomycoses | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Multivariate Analysis | Drug Administration Schedule | Hematologic Neoplasms - mortality | Humans | Middle Aged | Zygomycosis - microbiology | Zygomycosis - mortality | Male | Antifungal Agents - therapeutic use | Time Factors | Adolescent | Amphotericin B - administration & dosage | Adult | Female | ROC Curve | Aged | Hematologic Neoplasms - complications | Immunocompromised Host | Amphotericin B - therapeutic use | Antifungal Agents - administration & dosage | Child | Zygomycosis - drug therapy | Mucormycosis | Amphotericin B | Patient outcomes | Dosage and administration | Research | Drug therapy | Fungi | Regression analysis | Medical diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Changing epidemiology of rare mould infections: Implications for therapy
by Malani, Anurag N and Kauffman, Carol A
Drugs (New York, N.Y.), ISSN 0012-6667, 2007, Volume 67, Issue 13, pp. 1803 - 1812
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Mycoses - epidemiology | Triazoles - administration & dosage | Humans | Zygomycosis - microbiology | Mycoses - microbiology | Aspergillosis - epidemiology | Antifungal Agents - therapeutic use | Zygomycosis - epidemiology | Pyrimidines - therapeutic use | Aspergillosis - microbiology | Mycoses - drug therapy | Voriconazole | Fusarium | Antifungal Agents - administration & dosage | Drug Resistance, Fungal | Zygomycosis - drug therapy | Aspergillosis - drug therapy | Scedosporium | Triazoles - therapeutic use
Journal Article
Details down arrow
3. Full Text Posaconazole as Salvage Therapy for Zygomycosis
by R. N. Greenberg and K. Mullane and J.-A. H. van Burik and I. Raad and M. J. Abzug and G. Anstead and R. Herbrecht and A. Langston and K. A. Marr and G. Schiller and M. Schuster and J. R. Wingard and C. E. Gonzalez and S. G. Revankar and G. Corcoran and R. J. Kryscio and R. Hare
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2006, Volume 50, Issue 1, pp. 126 - 133
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Pharmacology. Drug treatments | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antifungal Agents - pharmacology | Triazoles - administration & dosage | Fungi - drug effects | Administration, Oral | Humans | Middle Aged | Zygomycosis - microbiology | Male | Treatment Outcome | Antifungal Agents - therapeutic use | Triazoles - pharmacology | Antifungal Agents - pharmacokinetics | Adolescent | Adult | Female | Triazoles - pharmacokinetics | Aged | Immunocompromised Host | Antifungal Agents - administration & dosage | Child | Zygomycosis - drug therapy | Triazoles - therapeutic use | Index Medicus | Clinical Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Antifungal therapy in invasive fungal infections
by Chen, Sharon C-A and Playford, E Geoffrey and Sorrell, Tania C
Current opinion in pharmacology, ISSN 1471-4892, 2010, Volume 10, Issue 5, pp. 522 - 530
Internal Medicine | Medical Education | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Cryptococcosis - microbiology | Humans | Zygomycosis - microbiology | Mycoses - microbiology | Cryptococcosis - drug therapy | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Candidiasis - drug therapy | Aspergillosis - microbiology | Mycoses - drug therapy | Zygomycosis - drug therapy | Aspergillosis - drug therapy | Practice Guidelines as Topic | Mycoses | Cross infection | Nosocomial infections | Triazoles | Health aspects | Antifungal agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole
by Alexander Imhof and S. Arunmozhi Balajee and David N. Fredricks and Janet A. Englund and Kieren A. Marr
Clinical infectious diseases, ISSN 1058-4838, 9/2004, Volume 39, Issue 5, pp. 743 - 746
Antifungals | Fungi | Aspergillus | Azoles | Brief Reports | Lungs | Myeloid leukemia | Aspergillosis | Infections | Transplantation | Fungal infections | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Medical sciences | Bacterial sepsis | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Candida glabrata - physiology | Humans | Middle Aged | Drug Resistance, Fungal - physiology | Fungi - isolation & purification | Male | Microbial Sensitivity Tests | Candidiasis - drug therapy | Fungemia - drug therapy | Fungi - physiology | Voriconazole | Aspergillus - isolation & purification | Adult | Female | Immunocompromised Host - physiology | Retrospective Studies | Child | Zygomycosis - drug therapy | Aspergillosis - drug therapy | Triazoles - therapeutic use | Fungi - drug effects | Drug Resistance, Fungal - drug effects | Fungemia - metabolism | Candida glabrata - metabolism | Aspergillus - drug effects | Candidiasis - metabolism | Pyrimidines - therapeutic use | Zygomycosis - metabolism | Candida glabrata - drug effects | Stem Cell Transplantation - adverse effects | Care and treatment | Research | Health aspects | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy
by Jenks, Jeffrey D and Reed, Sharon L and Seidel, Danila and Koehler, Philipp and Cornely, Oliver A and Mehta, Sanjay R and Hoenigl, Martin
International journal of antimicrobial agents, ISSN 0924-8579, 11/2018, Volume 52, Issue 5, pp. 706 - 712
Mucormycosis | Fusarium solani | Epidemiology | Scedosporiosis | Zygomycosis | Scedosporium | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Mucorales - isolation & purification | Humans | Middle Aged | Fusarium - drug effects | Male | Ascomycota - drug effects | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Young Adult | Invasive Fungal Infections - mortality | Invasive Fungal Infections - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Antifungal Agents - pharmacology | Ascomycota - isolation & purification | Invasive Fungal Infections - epidemiology | California - epidemiology | Mucorales - drug effects | Treatment Outcome | Adolescent | Survival Analysis | Aged | Invasive Fungal Infections - microbiology | Fusarium - isolation & purification | Analysis | Molds (Fungi) | Mortality | Antifungal agents | Drug therapy, Combination | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Combination Therapy for Mucormycosis: Why, What, and How?
by Brad Spellberg and Ashraf Ibrahim and Emmanuel Roilides and Russel E. Lewis and Olivier Lortholary and George Petrikkos and Dimitrios P. Kontoyiannis and Thomas J. Walsh
Clinical infectious diseases, ISSN 1058-4838, 1/2012, Volume 54, Issue suppl_1, pp. S73 - S78
Antifungals | Mucormycosis | Animal models | Mucorales | Polyenes | Lipids | Mice | Infections | Dosage | Zygomycosis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Triazoles - administration & dosage | Benzoates - therapeutic use | Humans | Treatment Outcome | Clinical Trials as Topic | Lipids - administration & dosage | Lipids - therapeutic use | Antifungal Agents - therapeutic use | Benzoates - administration & dosage | Echinocandins - administration & dosage | Polyenes - administration & dosage | Animals | Polyenes - therapeutic use | Mucormycosis - microbiology | Echinocandins - therapeutic use | Drug Therapy, Combination | Mucormycosis - drug therapy | Antifungal Agents - administration & dosage | Triazoles - therapeutic use | Clinical trials | Toxicity | Mortality | Medical treatment | Index Medicus | Supplement
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole
by Trifilio, S and Singhal, S and Williams, S and Frankfurt, O and Gordon, L and Evens, A and Winter, J and Tallman, M and Pi, J and Mehta, J
Bone marrow transplantation (Basingstoke), ISSN 0268-3369, 09/2007, Volume 40, Issue 5, pp. 451 - 456
Immunology | Life Sciences & Biomedicine | Hematology | Oncology | Transplantation | Biophysics | Science & Technology | Biological and medical sciences | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Triazoles - blood | Pyrimidines - blood | Humans | Drug Evaluation | Male | Data Collection | Transplantation, Homologous | Antifungal Agents - therapeutic use | Aspergillosis - prevention & control | Candidiasis - drug therapy | Pyrimidines - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Mycoses - drug therapy | Voriconazole | Pyrimidines - pharmacokinetics | Female | Triazoles - pharmacokinetics | Zygomycosis - drug therapy | Aspergillosis - drug therapy | Premedication | Triazoles - therapeutic use | Prevention | Mycoses | Health aspects | Risk factors | Hematopoietic stem cells | Methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Posaconazole Mono- or Combination Therapy for Treatment of Murine Zygomycosis
by Ashraf S. Ibrahim and Teclegiorgis Gebremariam and Julie A. Schwartz and John E. Edwards Jr and Brad Spellberg
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2009, Volume 53, Issue 2, pp. 772 - 775
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Pharmacology. Drug treatments | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Triazoles - administration & dosage | Brain - microbiology | Diabetic Ketoacidosis - complications | Kidney - pathology | Rhizopus | Zygomycosis - microbiology | Male | Antifungal Agents - therapeutic use | Dose-Response Relationship, Drug | Neutropenia - complications | Kidney - microbiology | Animals | Amphotericin B - administration & dosage | Brain - pathology | Mice | Mice, Inbred BALB C | Liposomes | Amphotericin B - therapeutic use | Antifungal Agents - administration & dosage | Drug Combinations | Zygomycosis - drug therapy | Triazoles - therapeutic use | Index Medicus | Experimental Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases
by Dimitrios P. Kontoyiannis and Michail S. Lionakis and Russell E. Lewis and Georgios Chamilos and Mimi Healy and Cheryl Perego and Amar Safdar and Hagop Kantarjian and Richard Champlin and Thomas J. Walsh and Issam I. Raad
The Journal of infectious diseases, ISSN 0022-1899, 4/2005, Volume 191, Issue 8, pp. 1350 - 1360
Antifungals | Fungi | Aspergillus | Predisposing factors | Aspergillosis | Infections | Fungal infections | Operating rooms | Sinusitis | Zygomycosis | Neutropenia | Fundamental and applied biological sciences. Psychology | Miscellaneous | Human mycoses | Infectious diseases | Tropical mycoses | Microbiology | Mycology | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Tumors | Antifungal Agents - pharmacology | Zygomycosis - complications | Zygomycosis - diagnosis | DNA Fingerprinting | Humans | Middle Aged | Risk Factors | Zygomycosis - microbiology | Male | Aspergillosis - epidemiology | Case-Control Studies | Neoplasms | Antifungal Agents - therapeutic use | Aspergillus - drug effects | Zygomycosis - epidemiology | Leukemia - complications | Aspergillosis - microbiology | Female | Aspergillus - physiology | Drug Resistance, Fungal | APACHE | Mucormycosis | Care and treatment | Research | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A First-Line Antiretroviral Therapy-Resistant HIV Patient with Rhinoentomophthoromycosis
by Dhurat, Rachita and Kothavade, Rajendra J and Kumar, Anand
Indian journal of medical microbiology, ISSN 0255-0857, 01/2018, Volume 36, Issue 1, pp. 136 - 139
antiviral drugs | AIDS | HIV | rhinoentomophthoromycosis | Conidiobolus coronatus | Life Sciences & Biomedicine | Immunology | Science & Technology | HIV Infections | Zygomycosis - complications | Anti-Retroviral Agents - therapeutic use | Tenofovir - therapeutic use | Humans | Zygomycosis - microbiology | Drug Resistance, Viral | Male | Potassium Iodide - therapeutic use | Antifungal Agents - therapeutic use | Atazanavir Sulfate - therapeutic use | Itraconazole - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Adult | Conidiobolus - drug effects | Immunocompromised Host | Drug Resistance, Fungal | Zygomycosis - drug therapy | Infection | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | HIV patients | Drug resistance | HIV (Viruses) | Itraconazole | Antiretroviral drugs | Therapy | Candidiasis | Fungicides | Mortality | Rhinoentomophthoromycosis | Antiretroviral therapy | Tuberculosis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Diagnostic systems
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights